A graduate student from the Massachusetts Institute of Technology (MIT) is poised to commercialize a new technology for improving the cost-effectiveness of mRNA manufacture. Nathan Stover is working ...
Creative Biolabs optimizes the mRNA drug development model by integrating sequence design, RNA-protein interaction verification, and preclinical development into a single process.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback